CUSIP: 286221106
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,427,407
-
Share change
-
+3,780,849
-
Total reported value
-
$5,869,084
-
Price per share
-
$1.05
-
Number of holders
-
24
-
Value change
-
+$4,069,615
-
Number of buys
-
13
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 286221106:
Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q1 2018
As of 31 Mar 2018,
ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,427,407 shares.
The largest 10 holders included
TRV GP, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, SABBY MANAGEMENT, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, and Bank of New York Mellon Corp.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.